Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT

Abstract Background The use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting and is being increasingly used in matched sibling (MSD) and matched unrelated (MUD) transplants. There is no info...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jaime Sanz, Jacques-Emmanuel Galimard, Myriam Labopin, Boris Afanasyev, Emanuele Angelucci, Fabio Ciceri, Didier Blaise, Jan J. Cornelissen, Ellen Meijer, J. L. Diez-Martin, Yener Koc, Montserrat Rovira, Luca Castagna, Bipin Savani, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-05-01
coleção:	Journal of Hematology & Oncology
Assuntos:	Post-transplant cyclophosphamide Haploidentical transplant Alternative donor transplants Acute leukemia Allogeneic stem cell transplant
Acesso em linha:	http://link.springer.com/article/10.1186/s13045-020-00882-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!